7-Bromo-4-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 97%, 250mg

4-NITRO-1,3-BENZOXAZOLE, 95.0%, 10g

2-Fluoro-5-(trifluoromethyl)benzylamine, 97.0%, 5g

4-(5-Phenyl-[1,2,4]oxadiazol-3-yl)-benzoic acid, 95.0%, 1g

2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide, 95.0%, 100g

3-[(2-furylmethyl)thio]-1-propanamine, 95.0%, 5g

Palmitate d'isopropyle, min 90 %, pour la synthèse, 1 l, emballage plastique.

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

3-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)benzene-1-sulfonamide, 95%, 5g

1,6-Dioxaspiro[2.5]octane, 95.0%, 100mg

(S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoic acid, 98%, 100mg

Hexyl Hexanoate>98.0%(GC)25mL

Quinoline-6-sulfonyl chloride, 95.0%, 250mg